Get the content you want anytime you want.
REGISTER NOW | SIGN IN

Select coverage from ID Week 2016 is included below:

A New Approach to Understanding Multidrug-resistant Infections
Vikas Gupta, PharmD, BCPS, director of Clinical Strategy at Becton Dickinson, explains his team’s unique approach to understanding multidrug-resistant infections.
Activist-driven Legislation and New Technology Have Improved US Food Safety
US food-safety legislation has toughened up as both regional and national centers strive to provide the public with safe food through the use of food-related disease surveillance programs and new technologies.
Effectiveness of Influenza Antiviral Treatment in Outpatient Settings
Rebekah Stewart Schicker, MSN, MPH, APRN, Epidemic Intelligence Service (EIS) Officer at the Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Influenza Division, explains how antiviral flu treatments may be affecting patients in the outpatient setting.
Ibalizumab Beneficial for Previously Treated Patients with Multi-Drug-Resistant HIV-1 Infection
The monoclonal antibody, ibalizumab, has proven to be both safe and effective in treating patients who are infected with multi-drug-resistant HIV-1 and have been previously treated.
Antimicrobial Stewardship for Outpatients: Progress, But a Long Way to Go
At the ID Week meeting in New Orleans, Louisiana, a trio of speakers addressed some of the outpatient challenges regarding antimicrobial stewardship.
Community Hospitals Lag Behind in Infection Control
Compared with bigger institutions, community hospitals are lacking when it comes to educating healthcare workers and providing effective infection control programs, which is compromising patient care, according to a presentation at ID Week 2016.
Fatal Measles Complication More Frequent Than Previously Thought
Researchers estimate that there are more cases of sclerosing panencephalitis (SSPE), a fatal measles complication, than previous thought.
Skin and Soft Tissue Infection Prevalence in the US
Michael D. Nailor, PharmD, BCPS-AQ ID, clinical associate professor at the University of Connecticut School of Pharmacy, clinical specialist in infectious diseases at Hartford Hospital, and director of Infectious Disease Residency program at Hartford Hospital, discusses the prevalence of skin and soft tissue infections in the United States.
FEATURED
We break down our top HIV news stories of 2017. Did you read them all?
x